Action brought on 16 July 2013 – Boehringer Ingelheim International/OHIM – Lehning entreprise (ANGIPAX)
(Case T-368/13)
Language in which the application was lodged: English
Parties
Applicant: Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany) (represented by: V. von Bomhard and D. Slopek, lawyers)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)
Other party to the proceedings before the Board of Appeal: Lehning entreprise SARL (Sainte Barbe, France)
Form of order sought
The applicant claims that the Court should:
Annul OHIM’s Fifth Board of Appeal’s decision of 29 April 2013 in Case R 571/2012-5 insofar as it allowed registration of the mark ANGIPAX in respect of pharmaceutical and veterinarian products and preparations for health and medical care; fungicides; dietetic substances adapted for medical use; disinfectants; surgical dressings and materials for dressing, materials for stopping teeth, preparations for destroying vermin; food for babies; and
Order that the costs of the proceedings be borne by the defendant, or - in the event that the other party before the Boards of Appeal intervenes on the side of the defendant - that they be borne jointly by the defendant and the intervener.
Pleas in law and main arguments
Applicant for a Community trade mark: The other party to the proceedings before the Board of Appeal
Community trade mark concerned: The word mark “ANGIPAX” for goods in class 5 – Community trade mark application No 8 952 401
Proprietor of the mark or sign cited in the opposition proceedings: The applicant
Mark or sign cited in opposition: The word mark “ANTISTAX” – Community trade mark registration No 2 498 343 for goods in classes 3, 5, 28 and 30
Decision of the Opposition Division: Rejected the opposition in its entirety
Decision of the Board of Appeal: Dismissed the appeal
Pleas in law: Infringement of Article 8(1)(b) of Council Regulation No 207/2009.